Although an increase in HUVEC viability became obvious, it did not reach statistical significance (Figure 3C , white bars, second triplet versus first triplet).
← all excerpts
The antiangiogenic action of cisplatin on endothelial cells is mediated through the release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells.
1
—
—